The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2019 | Progression of multiple myeloma novel therapies with Prof. Nagler
Speaking at the Controversies in Multiple Myeloma (Comy) 2019 World Congress in Paris, France, Arnon Nagler, MD, of the Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses the difference and progression of treatment options for multiple myeloma from 10 years ago compared to now. Prof. Nagler emphasizes the improvement in complete and overall response, but also the high cost of certain novel agents.
